Complement Genotype and Multiparametric Laboratory Analysis to Predict Response to Eculizumab and to Adjust Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

被引:0
|
作者
Subias-Hidalgo, Marta [1 ,2 ]
Lopez, Alicia [1 ,2 ]
Anter, Jaouad [1 ,2 ]
Pinto, Sheila [1 ,2 ]
Ojeda, Emilio [3 ]
Garcia-Marco, Jose A. [3 ]
Ataulfo Gonzalez-Fernandez, Fernando [4 ]
Fores, Rafael [3 ]
Llorente, Laura [3 ]
Maria Villegas-Martinez, Ana [4 ]
Rodriguez-Cordoba, Santiago [1 ,2 ]
机构
[1] CSIC, Ctr Invest Biol, Madrid, Spain
[2] Biol Complemento, Patol Mol, Madrid, Spain
[3] Univ Hosp Puerta de Hierro Majadahonda, Hematol, Majadahonda, Spain
[4] Hosp Clin San Carlos, Hematol, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12): : 1233 - 1243
  • [2] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
  • [3] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [4] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    [J]. Nature Biotechnology, 2007, 25 : 1256 - 1264
  • [5] Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment
    Subias Hidalgo, Marta
    Martin Merinero, Hector
    Lopez, Alicia
    Anter, Jaouad
    Pinto Garcia, Sheila
    Ataulfo Gonzalez-Fernandez, Fernando
    Fores, Rafael
    Lopez-Trascasa, Margarita
    Villegas, Ana
    Ojeda, Emilio
    Rodriguez de Cordoba, Santiago
    [J]. IMMUNOBIOLOGY, 2017, 222 (02) : 363 - 371
  • [6] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    [J]. BLOOD, 2007, 110 (12) : 4123 - 4128
  • [7] Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
    de Latour, Regis Peffault
    Fremeaux-Bacchi, Veronique
    Porcher, Raphael
    Xhaard, Alienor
    Rosain, Jeremie
    Castaneda, Diana Cadena
    Vieira-Martins, Paula
    Roncelin, Stephane
    Rodriguez-Otero, Paula
    Plessier, Aurelie
    de Fontbrune, Flore Sicre
    Abbes, Sarah
    Robin, Marie
    Socie, Gerard
    [J]. BLOOD, 2015, 125 (05) : 775 - 783
  • [8] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
    Rodriguez-Garcia, Juan
    Fernandez-Santos, Rafael
    Antonio Garcia-Erce, Jose
    [J]. MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
  • [9] Erythropoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria
    Hill, A.
    Richards, S. J.
    Rother, R. P.
    Hillmen, P.
    [J]. HAEMATOLOGICA, 2007, 92 (03) : E31 - E33
  • [10] Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    [J]. Nature Biotechnology, 2007, 25 : 1488 - 1488